In conclusion, hyperglycemia and hyperlipidemia can lead to the activation of NLRP3 inflammasomes, and their downstream molecules, including caspase-1, IL-1β, and IL-18, in the glomerular mesangium. Here, NLRP3 is linked to hyperlipidemia.